MEF2C TRANSCRIPTION FACTOR IS ASSOCIATED WITH THE GENETIC AND EPIGENETIC RISK ARCHITECTURE OF SCHIZOPHRENIA AND IMPROVES COGNITION IN MICE

Large scale consortia mapping the genomic risk architectures of schizophrenia provide vast amounts of molecular information, with largely unexplored therapeutic potential. We harnessed publically available information from the Psychiatric Genomics Consortium, and report MYOCYTE ENHANCER FACTOR 2C (M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Psychiatry
Main Authors: Mitchell, Amanda C., Javidfar, Behnam, Pothula, Venu, Ibi, Daisuke, Shen, Erica Y., Peter, Cyril J., Bicks, Lucy, Fehr, Tristan, Jiang, Yan, Brennand, Kristen J., Neve, Rachael L., Gonzalez-Maeso, Javier, Akbarian, Schahram
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5966823/
https://ncbi.nlm.nih.gov/pubmed/28115742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2016.254
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados